Sentiment skews more negative than the wider beat, at 71% negative against 30% across all 1057 Retail stories in the same window. They are better corroborated than the beat average, carrying 8.3 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about FDA
Sentiment skews more negative than the wider beat, at 71% negative against 30% across all 1057 Retail stories in the same window. They are better corroborated than the beat average, carrying 8.3 original sources each against 3.1 for the same window. Coverage clusters in consumer-trends, which accounts for 5 of those 7, with the remainder spread across 2 other categories. CDC is the most frequent co-covered peer, appearing in 2 of the 7 tracked stories. Across a 183-day span, the pace is roughly 0.3 stories per week. The 6.7 average consequence score is above the beat benchmark of 6.2 in the same window. FDA appears in 7 tracked Retail stories published from February 19, 2026 through August 20, 2026.
Stories tracked
7
Per week
0.3
Negative
71%
Sources per story
8.3
Computed from the 7 stories linked to this entity, with beat comparisons drawn from all 1057 Retail stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering FDA. Shared-story counts are live from our verified record — not editorial picks.
Publix's private-label GreenWise Organic frozen blueberries and mixed berries are under FDA Class 1 recall after 12 illnesses across two states, impacting all eight states where the grocer operates and shaking consumer trust in its premium organic brand.
The cyclospora outbreak traced to Taco Bell's lettuce supplier has sickened 1,644 customers, prompting a national menu intervention. For retail investors and restaurant operators, the immediate financial impact on Yum! Brands and the long-term consequences for consumer trust and brand loyalty are significant.
The FDA’s approval of bemotrizinol opens the door for U.S. sunscreen brands to offer more advanced, photostable formulas that have long been available in Europe and Asia. Retailers can expect a wave of product launches and a shift in consumer preferences toward this next-generation UV filter.
A nationwide recall has been issued for alcohol pads due to life-threatening bacterial contamination, forcing major retailers and e-commerce platforms to halt sales immediately. The recall highlights critical vulnerabilities in the medical supply chain and the challenges of managing reverse logistics for contaminated antiseptic products.
The FDA has initiated a nationwide recall of nearly 90,000 bottles of children's ibuprofen, forcing major retailers and e-commerce platforms to purge inventory. This large-scale safety action highlights critical vulnerabilities in pediatric pharmaceutical supply chains and consumer trust.
A widespread recall has been issued for a wellness supplement after testing revealed the presence of Sildenafil, the active pharmaceutical ingredient in Viagra. This discovery poses severe health risks to consumers with underlying conditions and underscores the persistent challenges of regulatory oversight in the online supplement market.
Amai Proteins has achieved a major regulatory milestone with the U.S. FDA’s GRAS approval for Sweelin, its designer protein sweetener. This clearance allows for the immediate integration of the sugar alternative into the U.S. food and beverage supply chain, targeting a $100 billion sugar-reduction market.